Mitiglinide calcium dihydrate

This classification denotes an anti-diabetic agent 2C19H24NO3.Ca.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9651C21W3Z, chemically known as bis((2s)-2-benzyl-3-(cis-hexahydroisoindolin-2-ylcarbonyl)propionate) calcium dihydrate, d-, but more generally known as mitiglinide calcium dihydrate, which bears US NIH Compound Identifier 6918235. European Medicines Agency schedules Mitiglinide calcium dihydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21788. Most nations, for tariff and trade purposes, schedule mitiglinide calcium dihydrate under HS 29339990 and SITC 51577. As of Q4 2014, MITIGLINIDE CALCIUM DIHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C1CCC(CC1)C[C@@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)C(=O)[O-].C1CCC(CC1)C[C@@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)C(=O)[O-].O.O.[CA+2].